Researchers develop efficient light-activated catalyst using minimal nickel for drug synthesis
Scientists at the Institute of Science and Technology Austria have designed a nickel catalyst that uses blue LED light to drive chemical reactions with significantly lower metal consumption than traditional methods. The new catalytic system selectively joins chemical building blocks through cross-coupling chemistry, a process essential for producing pharmaceuticals and fine chemicals. This light-driven approach offers greater efficiency, reduced cost, and improved sustainability for industrial chemical synthesis.
Cross-coupling chemistry has revolutionized pharmaceutical manufacturing since earning a Nobel Prize in 2010, but traditional palladium-based catalysts remain costly due to the metal's scarcity. Researchers have spent the past decade exploring nickel alternatives, which promise lower expenses and environmental benefits, though earlier iterations struggled with efficiency and versatility limitations compared to their palladium counterparts.
The ISTA team's breakthrough involves designing a nickel catalyst system where blue LED light provides the energy needed to drive reactions. By carefully structuring the ligands—organic molecules that bind to the nickel atom—the researchers have engineered a more capable catalyst that requires minimal metal while maintaining selectivity and efficiency in joining molecular building blocks.
This development could reduce production costs for pharmaceutical and chemical manufacturers by lowering both material expenses and energy requirements. Widespread adoption of light-activated nickel catalysts may improve industrial sustainability by decreasing reliance on scarce precious metals and potentially lowering the environmental footprint of drug synthesis. However, adoption would depend on whether the approach proves scalable to industrial production volumes and remains competitive with existing palladium-based systems in real-world manufacturing conditions.